Study Of Diabetic Nephropathy with Atrasentan

• Research type

  Research Study

• Full title

  A Randomized, Multicountry, Multicenter, Double-Blind, Parallel, Placebo-Controlled Study of the Effects of Atrasentan on Renal Outcomes in Subjects with Type 2 Diabetes and Nephropathy SONAR: Study Of Diabetic Nephropathy with Atrasentan

• IRAS ID

  133969

• Contact name

  Luigi Gnudi

• Contact email

  luigi.gnudi@kcl.ac.uk

• Sponsor organisation

  AbbVie Deutschland GmbH & Co KG.

• Eudract number

  2012-005848-21

• ISRCTN Number

  n/a

• REC name

  London - Hampstead Research Ethics Committee

• REC reference

  13/LO/1520

• Date of REC Opinion

  18 Dec 2013

• REC opinion

  Further Information Favourable Opinion